Stockreport

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pione [Read more]